Last reviewed · How we verify
NCT06253676: StandStrong
Sensing Technologies for Maternal Depression Treatment in Low-Resource Settings
NA trial testing Problem Management Plus (PM+) in Post Partum Depression in 120 participants. Currently enrolling.
31 August 2026
Quick facts
| Lead sponsor | George Washington University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 15 May 2024 |
| Primary completion | 31 August 2026 |
| Estimated completion | 31 August 2026 |
| Sites | 1 location across Nepal |
Drugs / interventions tested
- Problem Management Plus (PM+)
Conditions studied
- Post Partum Depression — all drugs for Post Partum Depression →
Sponsor
George Washington University
Who can join
Adults 15 to 45, female only, with Post Partum Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In certain low- and middle- income country settings, there is a disproportionate level of untreated postpartum depression that presents both acute and long-term risks to a mother's well-being. Although there is increasing willingness among health systems to involve non-specialists, such as community health workers, in the delivery of psychosocial interventions for postpartum depression, the effectiveness of these interventions has been mixed. The incorporation of digital technology, though, has the potential to improve the effectiveness of non-specialist-delivered interventions. The goal of this clinical trial is to evaluate the acceptability and clinical efficacy of the StandStrong intervention- a non-specialist, passive sensing technology-informed (i.e., digital) mental health intervention- as compared to a standard non-specialist mental health intervention among postpartum-depressed mothers in Nepal. Successful completion of the trial will contribute to the optimization of psychosocial intervention delivery for the postpartum context in low- and middle-income country settings.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06253676
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Problem Management Plus (PM+)
Trials testing the same drug.
- NCT06988332 — Problem Management Plus (PM+) in Chile: a Pilot Randomized Controlled Trial of a Psychological Transdiagnostic Intervent · NA · completed
- NCT05927987 — Feasibility and Acceptability of Problem Management Plus (PM+) for Prisoners in the Netherlands - a Pilot RCT · NA · recruiting
- NCT06026306 — A Scalable Psychological Intervention for Earthquake Survivors in Türkiye · NA · completed
- NCT05993507 — Mental Health Outcomes of Earthquake Survivors in Türkiye · NA · completed
- NCT04980326 — A Scalable Psychological Intervention to Reduce Psychological Distress Among Healthcare Workers · NA · completed
Other recruiting trials for Post Partum Depression
Currently open trials in the same condition.
- NCT06991166 — OBWELL: Innovative Psychotherapeutic Intervention to Treat Postpartum Depression · NA · recruiting
- NCT06968390 — Accelerated TMS for Perinatal Depression · NA · recruiting
- NCT05268588 — mHealth India Postnatal Health Intervention Effectiveness · NA · recruiting
- NCT04845230 — Fresh RX: NHS 2020 · NA · recruiting
- NCT04940585 — ROSE in Sunset Park · NA · recruiting
Other George Washington University trials
Trials by the same sponsor.
- NCT07279129 — Decision Support Tool to Integrate PrEP Into Emergency Departments · Phase 1 · not yet recruiting
- NCT07524309 — Self-Help Plus Pilot Study, Colombia: Train2Care · NA · not yet recruiting
- NCT07249008 — NSS Grocery Store Brazil · NA · recruiting
- NCT07000513 — HIV Self-Testing and Long-Acting Injectables for HIV Treatment and Prevention Among Commercial Minibus Drivers (I-TEST L · Phase 4 · not yet recruiting
- NCT07079306 — ChatGPT-Supported Text Messaging Program for Smoking Cessation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06253676 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by George Washington University
- Last refreshed: 25 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06253676.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing